J Eskola
Overview
Explore the profile of J Eskola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
241
Citations
2613
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kotilainen H, Valtonen V, Tukiainen P, Poussa T, Eskola J, Jarvinen A
Eur J Clin Microbiol Infect Dis
. 2015 Jul;
34(9):1909-18.
PMID: 26155783
We compared the clinical findings and survival in patients with Mycobacterium avium complex (MAC) and other non-tuberculous mycobacteria (NTM). A total of 167 adult non-human immunodeficiency virus (HIV) patients with...
2.
Lyytikainen O, Kuusi M, Snellman M, Virtanen M, Eskola J, Ronkko E, et al.
Euro Surveill
. 2011 Jul;
16(27).
PMID: 21794216
No abstract available.
3.
Eskola J
J Intern Med
. 2010 Mar;
267(3):241-50.
PMID: 20201918
An effective vaccine to prevent invasive infections caused by Haemophilus influenzae type b (Hib) bacteria has been available for more than 20 years. Hib conjugate vaccine is safe, efficacious and...
4.
Walker K, Brennan M, Ho M, Eskola J, THIRY G, Sadoff J, et al.
Vaccine
. 2010 Jan;
28(11):2259-70.
PMID: 20074686
Infection with Mycobacterium tuberculosis continues to be a major public health burden in most developing parts of the world and efforts to develop effective strategies for containing the disease remain...
5.
Waligorski M, Baranczyk R, Hyodynmaa S, Eskola J, Lesiak J, Rozwadowska-Bogusz B, et al.
Radiat Prot Dosimetry
. 2006 Apr;
120(1-4):74-7.
PMID: 16644929
Initial results are reported of a Polish-Finnish project to verify electron dose distributions calculated by treatment planning systems (TPSs), CadPlan v.6.3.2 and Theraplan v.3.5, which use different electron beam dose...
6.
7.
8.
Olander R, Wuorimaa T, Kayhty H, Leroy O, Dagan R, Eskola J
Vaccine
. 2001 Oct;
20(3-4):336-41.
PMID: 11672895
We measured the tetanus and diphtheria antitoxin responses after administration of one dose of a mixed carrier (tetanus and diphtheria toxoids) 11-valent pneumococcal conjugate vaccine (PncDT) in 20 Finnish adults...
9.
Wuorimaa T, Dagan R, Vakevainen M, Bailleux F, Haikala R, Yaich M, et al.
J Infect Dis
. 2001 Oct;
184(9):1211-5.
PMID: 11598848
Finnish and Israeli infants received an 11-valent mixed-carrier pneumococcal conjugate vaccine with or without aluminum adjuvant at 2, 4, 6, and 12 months of age. The relative avidity of serotype...
10.
Nurkka A, Ahman H, Yaich M, Eskola J, Kayhty H
Vaccine
. 2001 Sep;
20(1-2):194-201.
PMID: 11567764
We studied the immunogenicity of two octavalent pneumococcal (Pnc) conjugate vaccines; Pnc polysaccharides (PS) of serotypes 3, 4, 6B, 9V, 14, 18C, 19F, and 23F were conjugated to diphtheria or...